Our previous in silico protein–protein interaction (PPI) and molecular docking studies revealed that the isoquercitrin compound could trigger potential cancer-causing gene targets, such as IGF1R, PIK3CA, IL6, and PTGS2, which can regulate kidney cancer and inflammation (Figure 1). Here, IGF1R is linked to kidney cancer.